Pfizer has announced that it plans to increase the list price of 41 medicines, or 10% of its entire drug portfolio, as of January 15. The company indicated that “the increase in list price to this subset of [our] portfolio will be 5%,” with the only exceptions being three drugs, which will see their prices rise 3%, and one other product, whose cost will jump 9%. List prices for the remainder of the portfolio will be unchanged, the drugmaker said.
Read full article here: https://goo.gl/uZ7A5d as written by Joe Barber